Xencor

Filed a patent for "anti-cd28 x anti-ceacam5 antibodies" on Tue, March 14, 2023

Filed a patent for "anti-cd28 x anti-steap1 antibodies" on Tue, March 14, 2023

Filed a patent for "anti-cd28 x anti-ceacam5 antibodies" on Thu, April 13, 2023

Filed a patent for "anti-cd28 x anti-steap1 antibodies" on Fri, April 14, 2023

Filed a patent for "anti-cd28 x anti-ceacam5 antibodies" on Thu, August 24, 2023

Filed a patent for "orthogonal multimeric proteins" on Fri, April 28, 2023

Filed a patent for "anti-steap1 antigen-binding protein" on Thu, September 12, 2024

Filed a patent for "fc variants with altered binding to fcrn" on Thu, July 18, 2024

Filed a patent for "anti-cd28 x anti-psma antibodies" on Thu, July 4, 2024

Filed a patent for "lag-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and lag-3 antigen binding domains" on Wed, July 6, 2022

Filed a patent for "trispecific antibodies" on Thu, March 23, 2023

Filed a patent for "il-18-fc fusion proteins" on Thu, May 11, 2023

Filed a patent for "heterodimeric antibodies that bind enpp3 and cd3" on Thu, July 20, 2023

Filed a patent for "il-12 heterodimeric fc-fusion proteins" on Thu, January 26, 2023

Filed a patent for "methods and compositions for inhibiting cd32b expressing cells in igg4-related diseases" on Thu, July 20, 2023

Filed a patent for "methods for the treatment of plaque psoriasis" on Wed, September 7, 2022

Filed a patent for "lag-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and lag-3 antigen binding domains" on Mon, September 19, 2022

Filed a patent for "bispecific checkpoint inhibitor antibodies" on Thu, February 9, 2023

Filed a patent for "antibodies that bind pd-l1, pd-l2, and/or cd28" on Tue, October 11, 2022

Filed a patent for "tim-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and tim-3 antigen binding domains" on Thu, October 19, 2023

Filed a patent for "targeted heterodimeric fc fusion proteins containing il-15/il-15ra and nkg2d antigen binding domains" on Thu, October 26, 2023

Filed a patent for "methods for the treatment of plaque psoriasis" on Mon, November 7, 2022

Filed a patent for "combination treatment with a bispecific antibody that binds ctla4 and pd1 for prostate cancer" on Mon, November 7, 2022

Filed a patent for "natural killer cell antibodies with increased adcc activity" on Mon, November 7, 2022

Filed a patent for "bispecific antibodies that bind to b7h3 and mica/b" on Mon, November 7, 2022